304 related articles for article (PubMed ID: 30126231)
1. Implications of Metal Binding and Asparagine Deamidation for Amyloid Formation.
Sadakane Y; Kawahara M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126231
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
3. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration.
Maïza A; Chantepie S; Vera C; Fifre A; Huynh MB; Stettler O; Ouidja MO; Papy-Garcia D
FEBS Lett; 2018 Dec; 592(23):3806-3818. PubMed ID: 29729013
[TBL] [Abstract][Full Text] [Related]
4. [Crosstalk between metals and neurodegenerative diseases].
Kawahara M; Mizuno D
Nihon Eiseigaku Zasshi; 2014; 69(3):155-65. PubMed ID: 25253517
[TBL] [Abstract][Full Text] [Related]
5. The secret life of extracellular vesicles in metal homeostasis and neurodegeneration.
Bellingham SA; Guo B; Hill AF
Biol Cell; 2015 Nov; 107(11):389-418. PubMed ID: 26032945
[TBL] [Abstract][Full Text] [Related]
6. Role of cellular prion protein in interneuronal amyloid transmission.
Del Río JA; Ferrer I; Gavín R
Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
[TBL] [Abstract][Full Text] [Related]
7. Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases.
Kawahara M; Kato-Negishi M; Tanaka K
Metallomics; 2017 Jun; 9(6):619-633. PubMed ID: 28516990
[TBL] [Abstract][Full Text] [Related]
8. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.
Gaeta A; Hider RC
Br J Pharmacol; 2005 Dec; 146(8):1041-59. PubMed ID: 16205720
[TBL] [Abstract][Full Text] [Related]
9. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
Huang L; Liu X; Cheng B; Huang K
Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529
[TBL] [Abstract][Full Text] [Related]
10. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.
Price DL; Borchelt DR; Sisodia SS
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6381-4. PubMed ID: 8101988
[TBL] [Abstract][Full Text] [Related]
12. Role of metal ions in the abeta oligomerization in Alzheimer's disease and in other neurological disorders.
Drago D; Bolognin S; Zatta P
Curr Alzheimer Res; 2008 Dec; 5(6):500-7. PubMed ID: 19075576
[TBL] [Abstract][Full Text] [Related]
13. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
14. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
[TBL] [Abstract][Full Text] [Related]
15. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
[TBL] [Abstract][Full Text] [Related]
16. [Formation and participation of nano-amyloids in pathogenesis of Alzheimer's disease and other amyloidogenic diseases].
Mal'tsev AV; Galzitskaia OV
Biomed Khim; 2010; 56(6):624-38. PubMed ID: 21395066
[TBL] [Abstract][Full Text] [Related]
17. Commentary to "Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease".
Mandal PK; Pettegrew JW
Neurochem Res; 2008 Jun; 33(6):1168. PubMed ID: 18049892
[No Abstract] [Full Text] [Related]
18. Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
Colom-Cadena M; Gelpi E; Charif S; Belbin O; Blesa R; Martí MJ; Clarimón J; Lleó A
J Neuropathol Exp Neurol; 2013 Dec; 72(12):1203-12. PubMed ID: 24226269
[TBL] [Abstract][Full Text] [Related]
19. A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases.
Borza LR
Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):19-27. PubMed ID: 24741770
[TBL] [Abstract][Full Text] [Related]
20. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
